Discover 1,839 paid clinical trials in Lakeland, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,839
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Clermont FL, Orange City FL, Atlanta GA, Louisville KY,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 18+
Code: NCT04198766
Phase1, Phase2, Recruiting
GEMINI-NSCLC: NSCLC Biomarker Study
for
Non-Small Cell Lung Cancer
Location: Clermont FL, Charleston SC, Atlanta GA, Birmingham AL,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT05236114
Recruiting
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Clermont FL, Fort Myers FL, West Palm Beach FL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136559
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously Enrolled in a KT-621 Asthma Study
for
Asthma (Diagnosis)
Location: Tampa FL, Miami FL, Dallas TX
Sponsor: Kymera Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07677059
Phase2, Recruiting
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
for
Binge-Eating Disorder
Location: Orlando FL, Fort Myers FL, Jacksonville FL,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 55
Code: NCT06413433
Phase3, Recruiting
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
for
Eosinophilic Asthma
Location: Tampa FL, Orlando FL, Loxahatchee Groves FL,
Sponsor: Kymera Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07323654
Phase2, Recruiting
Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer
for
Colonic Neoplasms, Rectal Neoplasms
Location: Orlando FL
Sponsor: AdventHealth Translational Research Institute
Sex: All
Age: 18+
Code: NCT05789433
Recruiting
New
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
for
Pulmonary Disease, Chronic Obstructive
Location: Tampa FL
Sponsor: GlaxoSmithKline
Sex: All
Age: 40 - 70+
Code: NCT07780656
Phase3, Recruiting
Study of ALTO-101 in Patients With Schizophrenia
for
Schizophrenia, Cognitive Impairment
Location: Tampa FL, Hollywood FL, Snellville GA, Gaithersburg MD,
Sponsor: Alto Neuroscience
Sex: All
Age: 21 - 55
Code: NCT06502964
Phase2, Recruiting
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
for
Atopic Dermatitis
Location: Tampa FL, Jacksonville FL, Miami FL, Macon GA,
Sponsor: LEO Pharma
Sex: All
Age: 0 - 11
Code: NCT06311682
Phase3, Recruiting
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
for
Migraine
Location: Tampa FL, Tamarac FL, Hialeah FL, Augusta GA,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT05156398
Phase3, Recruiting
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
Location: St. Petersburg FL, Orlando FL, Jacksonville FL,
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 0 - 1
Code: NCT05685745
Recruiting
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for
Diffuse Large B-Cell Lymphoma
Location: Clermont FL, Ocoee FL, Orange City FL, Bethesda MD,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06717347
Phase3, Recruiting
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
for
Hidradenitis Suppurativa
Location: Tampa FL, Sanford FL, Sweetwater FL, Columbus GA,
Sponsor: Incyte Corporation
Sex: All
Age: 12 - 70+
Code: NCT07049575
Phase1, Recruiting
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
for
Crohn's Disease
Location: Tampa FL, Kissimmee FL, Orlando FL, Dothan AL,
Sponsor: Takeda
Sex: All
Age: 18 - 70
Code: NCT06045754
Recruiting
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
for
Heart Failure, Acute Heart Failure
Location: Brooksville FL, Bradenton FL, Fort Myers FL, Tamarac FL,